Indications for home enteral nutrition (HEN) use
| Adults (n=50) | |
|---|---|
| A | |
| Malignancy | 24 (48%) |
| Neuromuscular degenerative disorder | 8 (16%) |
| Stroke | 4 (8%) |
| Respiratory disease | 4 (8%) |
| Brain injury | 3 (6%) |
| Congenital malformation | 3 (6%) |
| Unknown | 4 (8%) |
| Children (n=37) | |
| B | |
| Chromosomal/metabolic disorder | 9 (24.3%) |
| Cerebral palsy | 7 (18.9%) |
| Cystic fibrosis | 5 (13.5%) |
| Developmental delay | 5 (13.5%) |
| Congenital heart disease | 4 (10.8%) |
| Chronic kidney disease | 2 (5.4%) |
| Gastrointestinal tract congenital malformation | 2 (5.4%) |
| Malignancy | 1 (2.7%) |
| Unknown | 2 (5.4%) |
Patients were asked to complete the indication for initial prescription of HEN as part of the distributed questionnaire. A: Data are displayed as actual and percentage count of adult (n=50) and B: Paediatric (n=37) patients.